Richard S. Bedlack, MD, PhD, MS
Director, Duke ALS Clinic
Department / Division
Medicine /
Medicine-Neurology
Address
DUMC 3333
Durham, NC 27710
Appointment Telephone
919-668-7600
Office Telephone
919-668-2839
Fax Telephone
919-668-2901
- MD, PhD, University of Connecticut School of Medicine, 1995
- Neurology, Duke University Medical Center, 1996-1999
- Neuromuscular Disease, Duke University Medical Center, 1999-2000
- MS, Clinical Research, Duke University Medical Center, 2004
Clinical Interests
All neuromuscular diseases, especially ALS, motorneuron disease, SMA, CMT, CIDP, diabetic neuropathy, myasthenia gravis, and LEMS
Research Interests
1. Investigator-initiated and multi-center clinical trials testing new treatments for amyotrophic lateral sclerosis and diabetic neuropathy.
2. Epidemiologic studies to better understand the causes and variability in prognosis of amyotrophic lateral sclerosis and diabetic neuropathy.
3. Basic science studies to develop novel biomarkers for amyotrophic lateral sclerosis.
This physician (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- ALS Association
- American Academy of Neurology
- Athena Diagnostics (Quest Diagnostics Inc.)
- Avanir Pharmaceuticals
- Biotechnology Greenhouse Corporation
- Coleman Research Group
- Curry Rockerfeller Group
- Guidepoint Clinical
- HCRC
- Health Advances
- Lilly (Eli Lilly)
- Partners
- Pfizer Inc.
- Research Triangle Institute (aka RTI International)
- Sanofi-Aventis
- UCB Pharma
- University of Mississippi
Representative Publications
Bedlack RS, Traynor BJ, Cudkowicz ME. Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis. Expert Opin Emerg Drugs. 2007 May;12(2):229-52.
(2007)
Abstract
Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, Hilton JF, Spitalny GM, MacArthur RB, Mitsumoto H, Neville HE, Boylan K, Mozaffar T, Belsh JM, Ravits J, Bedlack RS, Graves MC, McCluskey LF, Barohn RJ, Tandan R, . Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol. 2007 Dec;6(12):1045-53.
(2007)
Abstract
